Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

RSS icon

80% of patient advocacy groups take money from drug, device companies

The vast majority of the top nonprofit patient advocacy groups accepted donations from manufacturers of pharmaceuticals and medical devices, according to a new study published in the New England Journal of Medicine.

Thumbnail

HIMSS 2017: The connected healthcare revolution has started—but there are obstacles

Connected health using technologies has improved care delivery across the healthcare continuum. In a presentation at HIMSS 2017 in Orlando, Jeroen Tas, chief innovation and strategy officer at Royal Philips, examined the role of technology and barriers organizations may face in implementing connected health technology.

4 ways to improve doctor-patient communication

Improving communication between patients and physicians is easier said than done. A recent study published in the American Journal of Medical Quality outlined how a hospital-wide communication training program was able to improve patients' perceptions by 9 percent.

Apps can boost healthy behaviors, if they properly engage users

Having productive conversations is the baseline in providing high quality care to patients, but can communication reach such a level through an app or website? Researchers conducted a study, published in Human Communication Research, testing the effectiveness of online health tools when using different tones. 

Trial takes a different approach to classifying cancer treatment

A new study called the NCI-MATCH trial that analyzes patients’ tumors to determine whether they contain gene abnormalities for which a targeted drug exists and assigns treatment based on the abnormality has gained popularity since its open enrollment in August 2015.

HIMSS 2017: Wearable-gathered data improves care for seniors

J. Patrick Bewley, CEO of Big Cloud Analytics, and Moulay Elalamy, VP of information technology at Benchmark Senior Living, presented a study at HIMSS 2017 in Orlando on the effects of wearable technology on seniors living in a community center.

HIMSS 2017: How digital tech can boost social determinants of health

The social determinants of health (SDOH) are conditions such as geographic location, genetics, diet and education that can impact the health of population groups. In a session at HIMSS 2017 in Orlando, Jane Sarasohn-Kahn, MA, MHSA, discussed how technological advancements can engage consumers and providers to address these SDOH that can improve or diminish health risks.

Continuous glucose monitoring effective with or without blood glucose monitoring measurement

In patients with Type 1 diabetes, having correct glucose levels is the first step in high quality care. A recent study, published in Diabetes Care, tested the effectiveness in continuous glucose monitoring (CGM) with and without blood glucose monitoring (BGM) measurement. 

Displaying 1641 - 1648 of 3249

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.